Recent Updates
Recently added Catalysts

Upcoming Catalyst

Drug Pipeline Intelligence

Clinical Trial Results

Inside Trades

Options Data

News Section

Hedge Funds

Ownership Trends

Competitive Position

Eton Pharmaceuticals, Inc.

35 indications, side-by-side phase, drug & LoA

$30.53

+0.58 (+1.94%)

Market Cap
892.72 M
EPS
-0.06
P/E Ratio
-
Value Trade
9.06 M
SEC Financials
Q1 2026

  • Dilution Risk

    5%

  • Revenue

    24.27 M

  • R&D Expenses

    1.88 M

  • Operating CF

    7.41 M

  • Total Assets

    97.71 M

  • Total Liabilities

    67.09 M

  • Equity

    30.61 M

  • D/E Ratio

    12,345

12.22 %
Week
38.27 %
1 Month
79.46 %
3 Month
99.94 %
6 Month
289.37 %
5 Year
410.02 %
All Time
Cash Data
Profitable

  • Cash Position

    19.66 M

  • Monthly Burn

    -

  • Runway

    12,345 mo

  • Burn Trend

    Stable

  • SEC Filing

    May 14, 2026
Overview
Volume
219.19 K
52 Week Range
13.09 - 35.66
% held by Insiders
4.5 %
% held by Institutions
65.17 %
Enterprise Value
904.32 M
Total Shares
27.37 M
Short %
5.92 %
Float Shares
24.33 M
Company Description
HQ: 21925 W. FIELD PARKWAY, DEER P...
Employees:44
https://www.etonpharma.com

locked

Upcoming Catalyst
Catalyst Drug/Treatment Stage Probability of Approval Description Drug Type Therapeutic Area Source
NDA Submission example
KHINDIVI™ (hydrocortisone) Oral Solution Pediatric patients with adrenocortical insufficiency
NDA
-
Hormone Therapies
Endocrine System
KHINDIVI™ (hydrocortisone) Oral Solution Pediatric patients with adrenocortical insufficiency
NDA
-
Hormone Therapies
Endocrine System
KHINDIVI™ (hydrocortisone) Oral Solution Pediatric patients with adrenocortical insufficiency
NDA
-
Hormone Therapies
Endocrine System
Unlock Upcoming Catalyst data
Drug Pipeline Intelligence
Unlock Drug Pipeline Intelligence
ETON Clinical Trial Results & History
Drug Name Indications Phase Date Trial Results Summary Title Source
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Unlock Clinical Trial Results data
Inside Trades
TREND
CORPORATE INSIDERS BOUGHT SHARES WORTH 1.8M IN THE LAST 3 MONTHS
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Unlock Inside Trades data
Show Data
Hedge Funds
TREND
HEDGE FUNDS INCREASED HOLDINGS BY 200.0K SHARES IN THE LAST QUARTER
Shares Held
2040.00B1530.00B1020.00B510.00B0
Q3
2024
Q4
2024
Q1
2025
Q2
2025
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Fund Count
60%
Share Volume
25%
Conviction
15%
Hedge Funds invested in ETON
HedgeFund Name
( 3 )
% of Portfolio Current MV
-
Shares Owned
-
Activity
Avg Price $0

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K
Unlock Hedge Funds table data
Eton Pharmaceuticals, Inc. (ETON) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
ETON
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
ETON
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
ETON
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
Unlock Biotech Analyst Ratings data
ETON Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
Unlock Price Target Trend
ETON Institutional Ownership Trends
Current Insider %
5.20%
-+0.00%
Current Institutional %
62.40%
-+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
ETON Option Chain Statistics
ExpirationVolumeOpen InterestImplied Volatility CallsImplied Volatility Puts
CallsPutsPut-Call RatioCallsPutsPut-Call RatioIVOiWaIvVWaIvIVOiWaIvVWaIv
2026-08-21 0.00 0 - - - - - -
2026-08-21 0.00 0 - - - - - -
2026-08-21 0.00 0 - - - - - -
Unlock Option Chain Statistics data
Real-Time ETON Option Chain
CallsStrikePuts
Last PriceVolumeOpen InterestLast PriceVolumeOpen Interest
No data available
Unlock Option Chain data
Unlock Options Chart data
Open interest
0 600K 1.2M 1.8M Avg OI 1.00 M Open Interest
0 1 2 3 1.1 Put-Call Ratio
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
ETON Option Volume & Put-Call Ratio
0 450K 900K 1.4M Avg OV 750.00 K Option Volume
0 1 2 3 0.95 Put-Call Ratio
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Latest Eton Pharmaceuticals, Inc. (ETON) News & Alerts
-
Wednesday, June 10, 2026
(%)
+ More

Demo Biotech Announces Positive Phase 3 Results

Competitive Position
How ETON ranks across every disease it competes in
No competitive intelligence available for ETON.